kringle-pharmaCo., Ltd.

NEWS

notice

Oct 01, 2008 Notice

Kringle Pharma Files IND Application to FDA to Conduct Studies on recombinant human HGF for the Treatment of ARF.

Kringle Pharma Files IND Application to FDA to Conduct Studies on recombinant human HGF for the Treatment of ARF.